Note: Ingredients listed on restricted chemical lists
EC/CAS
201-788-0/9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
238-877-9/99880-64-5
Name of the chemical
glycerol dibehenate
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
>10,000
General Information
Version
4
Revision date
2022-04-07
Product name
Fesoterodine Fumarate Tablets
Product name
Fesoterodine Fumarate Tablets
Identification on the label/Trade name
TOVIAZ
Product Synonyms
Fesoterodine Sustained Release (SR) Tablets
Chemical name
Not determined
Emergency telephone
ChemSafe (24 hours) +44 (0)208 762 8322
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361d
Hazard statements
Code
Statements
H361d
Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Reproductive toxicity Category 2 - (H361d)
Signal word
Warning
Hazard statements
H361d - Suspected of damaging the unborn child
Precautionary statements
P202 - Do not handle until all safety precautions have been read and understood P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations
Other hazards
An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
